Astrotech Corporation (NASDAQ:ASTC) shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm. The stock boasts a consensus analyst “Buy” rating with the consensus recommendation standing at 2.00. This is according to all covering research brokerage firms taken into consideration by First Call. The consensus price target of $5.00 also implies significant upside from the current price of $0.88.
Astrotech Corporation (NASDAQ:ASTC)’s shares may have a significant upside to the consensus target of 5.00, but how has it been performing relative to the market? The stock’s price is 0.88 and their relative strength index (RSI) stands at 64.51. RSI is a technical oscillator that shows price strength by comparing upward and downward movements. It indicates oversold and overbought price levels for a stock.
Astrotech Corporation (NASDAQ:ASTC) shares are moving 29.41% trading at $0.88 today.
Stock research firms currently have a positive stance on shares of Abeona Therapeutics Inc. (NASDAQ:ABEO). Analysts are projecting that the stock will reach $19.40 on a short term (1 year) basis.
The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.80. This is based on the research brokerage reports taken into consideration by Thomson Reuters.
At the time of writing, the stock was trading at $17.20. This represents a change from most recent open price of 18.62%. In terms of performance, year to date, the stock is 254.64%. The monthly stock performance comes in at 102.35%. For the quarter, shares are performing at 265.96%. Weekly performance analysis shows the equity at 24.19%.
In taking a look at technical levels, shares are trading 76.52% away from the 50 day simple moving average and 167.73% away from the 200 day simple moving average. Based on a recent bid, the stock is trading 12.82% away from it’s 52- week high and 324.69% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Abeona Therapeutics Inc.’s RSI stands at 80.47. In looking at volatility levels, the shares saw weekly volatility of 7.58% and 11.48% over the past month.